Growing Companies in the South Korea Acyclovir Market | Insights & Key Players 2026

Growing Companies in the South Korea Acyclovir Market

The South Korea Acyclovir Market is segmented by the presence of global pharmaceutical companies and high-capacity domestic manufacturers competing for the market share with sophisticated antiviral formulations and strong distribution networks. GSK Korea, Hanmi Pharm and Daewoong Pharmaceutical are among the major players in the market.

South Korea Acyclovir Market Overview

According to 6Wresearch, the South Korea Acyclovir Market is growing at a steady pace, on account of the rising prevalence of the viral infections such as Herpes Simplex (HSV), Varicella-Zoster (shingles) and chicken pox. Acyclovir is a synthetic nucleoside analogue and an essential antiviral agent that inhibits viral DNA synthesis.

The development of the market is due to the increasing availability of antiviral drugs in healthcare facilities. The Korean population have been benefited from the successful development of topical and oral drug delivery systems, and the inclusion of Acyclovir in the National Health Insurance (NHI) reimbursement schemes, making these therapies indispensable.

Competitive Landscape

The competitive landscape of the South Korea Acyclovir Industry includes major multinational pharma companies and dominant domestic players. The dominant companies have an extensive experience in infectious diseases and dermatology, and are dedicated to enhance patients' health and wellbeing, by ensuring access to high-quality, antiviral agents in a variety of forms, such as tablets, creams and ophthalmic ointments.

Below is a list of leading players operating in the South Korea Acyclovir Market:

1. GSK Korea (GlaxoSmithKline)

GSK is the innovator behind Zovirax, a global standard for Acyclovir, and maintains a dominant position in the premium antiviral segment.

2. Hanmi Pharm Co., Ltd.

Hanmi Pharm is a leader in R&D and drug delivery technology, providing widely accessible and high-efficacy Acyclovir formulations.

3. Daewoong Pharmaceutical Co., Ltd.

Daewoong is a major domestic player that offers a diverse range of antiviral treatments, focusing on advanced manufacturing standards and local distribution.

4. Yuhan Corporation

Yuhan is one of Korea's most respected pharmaceutical companies, known for its strong distribution network and diverse portfolio of essential medicines.

5. GC Biopharma (Green Cross)

GC Biopharma focuses on specialized therapeutic segments and provides high-standard antiviral agents to major hospitals and clinics across the country.

6. Dong-A ST Co., Ltd.

Dong-A ST is a key manufacturer of ethical drugs, utilizing advanced facilities to supply essential antiviral products throughout the Korean peninsula.

7. JW Pharmaceutical

JW Pharmaceutical specializes in high-quality hospital-grade medicines, offering specialized Acyclovir formulations that meet international quality benchmarks.

8. Boryung Pharmaceutical Co., Ltd.

Boryung plays a vital role in manufacturing and marketing generic antivirals for the local market.

9. Huons Co., Ltd.

Huons leverages an extensive retail and production network to ensure essential antiviral treatments reach local pharmacies and clinics.

10. Kwangdong Pharmaceutical Co., Ltd.

Kwangdong focuses on marketing and distributing high-efficacy pharmaceutical products, including topical antiviral agents and wellness-oriented treatments.

Growing Companies in the South Korea Acyclovir Market: FAQs